Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s174613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search